Helpful Insights forPatients and Caregivers

Dietary and Herbal Supplements In Mental Health

Download PDF

Dietary supplements are products that are used to supplement the diet which may be useful in taking care of a disease or staying healthy.

References

  1. Dietary and herbal supplements. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/dietary-and-herbal-supplements. Published February 2020. Accessed September 10, 2021.
  2. Center for Food Safety and Applied Nutrition. Questions and answers on dietary supplements. U.S. Food and Drug Administration. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements. Published July 22, 2019. Accessed September 10, 2021.
  3. Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Can J Psychiatry. 2016;61(9):576-87. DOI: 10.1177/0706743716660290. PubMed PMID: 27486153; PubMed Central PMCID: PMC4994794.
  4. Nierenberg AA, Lund HG, Mischoulon D: St. John’s wort: a critical evaluation of the evidence of antidepressant effects. Natural Medications for Psychiatry: Considering the Alternatives. 2008;27-29.
  5. Moore LB, Goodwin B, Jones SA, et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnant X receptor. Proc Natl Acad Sci USA. 2000; 97:7500–7502
  6. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158(20):2200-11. DOI: 10.1001/archinte.158.20.2200. PubMed PMID: 9818800.
  7. Davis SA, Feldman SR, Taylor SL. Use of St. John's Wort in potentially dangerous combinations. J Altern Complement Med. 2014;20(7):578-9. DOI: 10.1089/acm.2013.0216. PubMed PMID: 24956073.
  8. Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms?. Sleep. 1997;20(10):908-15. DOI: 10.1093/sleep/20.10.908. PubMed PMID: 9415954.
  9. Arendt J. Jet-lag and shift work: (2). Therapeutic use of melatonin. J R Soc Med. 1999;92(8):402-5. DOI: 10.1177/014107689909200805. PubMed PMID: 10656005; PubMed Central PMCID: PMC1297315.
  10. Dollins AB, Lynch HJ, Wurtman RJ, Deng MH, Kischka KU, Gleason RE, et al. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology. 2nd edn.nd ed. 1993;112(4):490-6. DOI: 10.1007/BF02244899. PubMed PMID: 7871062.
  11. Partonen T. Melatonin-dependent infertility. Med Hypotheses. 1999;52(3):269-70. DOI: 10.1054/mehy.1997.0629. PubMed PMID: 10362288.
  12. Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin Psychiatry. 2010;71(6):669-81. DOI: 10.4088/JCP.10cs05959blu. PubMed PMID: 20573326.
  13. Smith K, Leiras C. The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials. Complement Ther Clin Pract. 2018;33:107-117. DOI: 10.1016/j.ctcp.2018.09.003. PubMed PMID: 30396607.
  14. Ooi SL, Henderson P, Pak SC. Kava for Generalized Anxiety Disorder: A Review of Current Evidence. J Altern Complement Med. 2018;24(8):770-780. DOI: 10.1089/acm.2018.0001. PubMed PMID: 29641222.
  15. White CM. The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava. J Clin Pharmacol. 2018;58(11):1396-1405. DOI: 10.1002/jcph.1263. PubMed PMID: 29791008.
  16. Mei N, Guo X, Ren Z, Kobayashi D, Wada K, Guo L. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2017;35(1):1-28. DOI: 10.1080/10590501.2016.1278298. PubMed PMID: 28055331.
  17. Diamond BJ, Bailey MR. Ginkgo biloba: indications, mechanisms, and safety. Psychiatric Clin North Am. 2013;36(1):73-83. DOI: 10.1016/j.psc.2012.12.006. PubMed PMID: 23538078.
  18. Bezchlibnyk-Butler KZ, Jeffries JJ, Virani AS. Clinical handbook of psychotropic drugs. 17th ed.  Hogrefe & Huber; 2007.